Natalie Mancuso

Healthcare and life sciences have long lagged in digital advertising, still focused on mass-audience approaches. But as the blockbuster drug era fades and precision medicine rises, broad strategies often fail to make precision therapies commercially viable – leaving life-changing treatments underutilized.